grant · US

Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)

National Institutes of Health

AT A GLANCE

About this opportunity

National Institutes of Health lists this grant. The listed closing date is 15 Oct 2027. Check the official listing for details.

Who it’s for

County governments; Public housing authorities/Indian housing authorities; Small businesses; Public and State controlled institutions of higher education; Native American tribal organizations (other than Federally recognized tribal governments); State governments; For profit organizations other than small businesses; Native American tribal governments (Federally recognized); Private institutions of higher education; Special district governments; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Independent school districts; City or township governments; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Others (see text field entitled "Additional Information on Eligibility" for…

Explore related listings

General information only, not advice. Govlark lists public opportunities that look relevant to the description given; it does not assess eligibility and does not say you qualify. Always read the official listing and guidelines before applying.

Source: US Government work (public domain) · Source: Grants.gov · Report an error